Dr. Pacheco on Frontline Therapy for Patients With EGFR-Mutant NSCLC
September 29th 2018Jose M. Pacheco, MD, an assistant professor of medicine/medical oncology at the Colorado University School of Medicine, discusses frontline therapy for patients with EGFR-mutant non–small cell lung cancer (NSCLC).
Read More